The medical term for the hormone corticosteroid is hydrocortisone. Corticosteroids are naturally produced by the adrenal gland within the adrenal cortex. Hydrocortisone is used to treat low hydrocortisone levels caused by Addison's disease, adrenocortical insufficiency, and various thyroid-related complications. It is used to treat allergic reactions (itching, swelling, redness), arthritis, neurological conditions (multiple sclerosis), lupus, certain types of cancers (leukemia, lymphoma, and multiple myeloma), and nausea and vomiting associated with some chemotherapy drugs.
The rising prevalence of diseases such as cancer, allergic reactions, arthritis, thyroid disease, and others is a major driver of the hydrocortisone market. In September 2018, the International Agency for Research on Cancer released a report titled GLOBOSCAN, which estimated the most recent cancer data.
Read more @ https://bit.ly/3eBafaK
Source:
https://www.coherentmarketinsights.com/ongoing-insight/hydrocortisone-market-2376
